Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00171587
Status:
COMPLETED
Last Update Posted:
2009-11-19
First Post:
2005-09-12
Brief Title:
Study of the Safety Tolerability Pharmacokinetics and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer
Sponsor:
Novartis
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CPTK787 0134306220
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
External Affairs
Old Organization:
Novartis
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |